Literature DB >> 1330296

Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.

S Joos1, F G Haluska, M H Falk, B Henglein, H Hameister, C M Croce, G W Bornkamm.   

Abstract

To analyze the region upstream of c-myc, a number of novel probes were established. These were generated by chromosomal walking starting from the breakpoint of the chromosomal translocation of the B-cell line 380 and by cloning the breakpoint of the translocation of the Burkitt lymphoma cell line IARC/BL72. Using the newly isolated probes a detailed physical map of 500 kilobases of the region upstream of c-myc was established applying pulsed-field gel electrophoresis. The chromosomal breakpoint of IARC/BL72 cells was mapped to a site 55 kilobases 5' of c-myc. A region 20 kilobases in length and containing the breakpoints of 380, EW36, P3HR-1, and Daudi cells was identified 170-190 kilobases upstream of c-myc. In addition the HPV18 integration site in HeLa cells was located between 340 and 500 kilobases 5' of c-myc. The probes were used to define the c-myc amplification units in Colo320-HSR and HL60 cells as well as in four cases of small cell lung cancer. Evidence is provided that the amplicon of HL60 cells is discontinuously organized.

Entities:  

Mesh:

Year:  1992        PMID: 1330296

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas.

Authors:  L Rajan; D Broussard; M Lozano; C G Lee; C A Kozak; J P Dudley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.

Authors:  Nicholas Chiorazzi; Manlio Ferrarini
Journal:  Blood       Date:  2010-12-09       Impact factor: 22.113

3.  Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas.

Authors:  K Basso; E Frascella; L Zanesco; A Rosolen
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Differential binding of replication proteins across the human c-myc replicator.

Authors:  Maloy Ghosh; Michael Kemp; Guoqi Liu; Marion Ritzi; Aloys Schepers; Michael Leffak
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications.

Authors:  J M Davison; T W Morgan; B L Hsi; S Xiao; J A Fletcher
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 6.  Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2014-04-21

7.  Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.

Authors:  Alexandra Valera; Samantha Epistolio; Lluis Colomo; Alice Riva; Olga Balagué; Ivan Dlouhy; Alexandar Tzankov; Marco Bühler; Eugenia Haralambieva; Elias Campo; Davide Soldini; Luca Mazzucchelli; Vittoria Martin
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

8.  Comparison Between Integrated Genomic DNA/RNA Profiling and Fluorescence In Situ Hybridization in the Detection of MYC, BCL-2, and BCL-6 Gene Rearrangements in Large B-Cell Lymphomas.

Authors:  Daniel P Cassidy; Jennifer R Chapman; Rafael Lopez; Kyle White; Yao-Shan Fan; Carmen Casas; Eric A Severson; Francisco Vega
Journal:  Am J Clin Pathol       Date:  2020-02-08       Impact factor: 2.493

9.  Identification of two enhancer elements downstream of the human c-myc gene.

Authors:  J Mautner; S Joos; T Werner; D Eick; G W Bornkamm; A Polack
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

Review 10.  DNA triple helices: biological consequences and therapeutic potential.

Authors:  Aklank Jain; Guliang Wang; Karen M Vasquez
Journal:  Biochimie       Date:  2008-02-21       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.